跳至主要内容
临床试验/JPRN-jRCTs011180023
JPRN-jRCTs011180023已完成未知

Development of photodynamic diagnostic method using aminolevulinic acid (5-ALA) against thoracic malignant tumors - PDTMT

Kitada Masahiro0 个研究点目标入组 267 人开始时间: 2019年3月19日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
267

研究概览

简要总结

We have developed an optical diagnostic method for pleural malignant lesions in combination with 5ALA, which is a photosensitive substance, and autofluorescence. As a result, localization diagnosis of lesions was possible, and pleural invasion factor could be diagnosed with sensitivity of 90.3% in the case of lung adenocarcinoma. It may contribute as a diagnostic method that complements conventional diagnostic imaging and visual diagnosis.

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 <= 80age old(—)
性别
All

入选标准

  • 1.Patients with chest malignancy (lung cancer, metastatic lung tumor, malignant breast tumor, thoracic lymph node metastasis from breast cancer) .
  • 2.Surgical samples with diagnosis of chest malignancy on image or pathological diagnosis.
  • 3.Cases requiring diagnosis by thoracoscopic biopsy including lymph nodes.
  • 4.After receiving sufficient explanation about this exam, after understanding the sufficient understanding, cases where document agreement was acquired with the free will of the patient himself / herself.

排除标准

  • 1. Cases of pregnancy or lactation.
  • 2. Patients with porphyria.
  • 3. Drugs that are known to cause photosensitivity: tetracycline antibiotics, sulfonamide type preparations, new quinolone type antibacterial agents, hypericin (Hypericum perforatum extract), etc. St. John's Wort patients who are receiving food containing.
  • 4. Cases with chronic hepatitis, chronic renalfailure.
  • 5. Cases in which the result of treatment of malignant tumor does not change by this procedure.

研究者

发起方
Kitada Masahiro

相似试验